Drugs continue to fail. Most candidates that enter into the development process do not come out the other end as approved therapies. But the reasons for those failures have shifted.
Last week, researchers from Oregon Health & Science University reported that they had created embryonic stem cells via somatic cell nuclear transfer (SCNT), with a high enough efficiency to bring the creation of patient-specific embryonic stem cell lines into the realm of the possible.
Flu pandemics are a sure thing. But what is not a sure thing at all is which viral strain will be the one to cause the next pandemic.
The most recent potential candidate is the H7N9 strain that first reared its head earlier this year. To date, there have been around 130 confirmed infections and 30 deaths from the new strain.
Like H5N1, the even more lethal strain of influenza that is still sporadically rearing its head, the number of cases has been small. But the worry is what will happen if the strain becomes easily transmissible.READ MORE »
- Alzheimer's Plaque Data Don't Hold Up, Behavioral Data Do »
- Sepsis Patients May Need Bigger Immune Response »
- No Working Kinase, but ErbB3 Acquires Oncogenic Mutations »
- Fungal Protein Points Way to New Breast Cancer Treatments »
- Short-lived Stem Cells Fight Brain Tumors, for a Time »
- Exhausted T Cells Can Rally Given Right Circumstances »
- Study Highlights New Target for Antidepressant Therapy »
- Adult Neurons Can Learn New Neurotransmitter 'Languages' »
- Study Could Lead to Inhibitors for Multidrug Molecular Pump »
- Biotech’s White Knight (aka Serial Cheater) Gets Prison Time, FinallyMay 03, 2013 | 3:41 PM | Posted by: Lynn Yoffee
- Where’s Superman When He’s Needed?April 30, 2013 | 10:07 AM | Posted by: Mari Serebrov
- Biopeople to Meet at BIO2013: Inside the World of Biotech’s Luminaries, Titans and BrainiacsApril 19, 2013 | 8:38 AM | Posted by: Lynn Yoffee
- Cancer Research Through Time: Cure Should’ve Been Wrapped up by 1985April 08, 2013 | 11:50 AM | Posted by: Anette Breindl
- ‘ImaginAb’ That! BioWorld Salutes ‘Overall Awesomeness’April 01, 2013 | 1:46 PM | Posted by: Jennifer Boggs
Cast Your Vote
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST